Diagnostic Advances in Multiple Myeloma.
Barley K et al. Curr Hematol Malig Rep. 2016 Feb 27. [Epub ahead of print].
Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.
Bolomsky A et al. Leuk Lymphoma. 2016 Mar 21:1-10. [Epub ahead of print].
Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques.
Rubini G et al. Crit Rev Oncol Hematol. 2016 Mar 5. pii: S1040-8428(16)30049-X. doi: 10.1016/j.critrevonc.2016.03.006. [Epub ahead of print].
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma.
Gonsalves WI et al. Leuk Res. 2016 Mar 10;44:32-39. doi: 10.1016/j.leukres.2016.03.003. [Epub ahead of print].
Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study.
Cordone I et al. J Exp Clin Cancer Res. 2016 Mar 19;35(1):49.
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.
Hillengass J et al. Br J Haematol. 2016 Mar 15. doi: 10.1111/bjh.14038. [Epub ahead of print].
Ultrasound of the nerves – An appropriate addition to nerve conduction studies to differentiate paraproteinemic neuropathies.
Athanasopoulou IM et al. J Neurol Sci. 2016 Mar 15;362:188-95. doi: 10.1016/j.jns.2016.01.055. Epub 2016 Jan 26.
Role of Flow Cytometry in the Diagnosis and Prognosis of Plasma Cell Myeloma.
Olteanu H. Surg Pathol Clin. 2016 Mar;9(1):101-16. doi: 10.1016/j.path.2015.09.009.